This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to determine the ability of In-DOTA-cT84.66 minibody fragments to localize to colorectal cancer, as determined by quantitative radioimmunoscintigraphy and biopsy samples.
Showing the most recent 10 out of 565 publications